Product Images Ranolazine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ranolazine NDC 90096-151 by Zameer Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label 1000 mg - image 3
This is a description of Ranolazine extended-release tablets with a strength of 1000 mg. The tablets should be swallowed whole and not crushed, broken, or chewed. They should be stored at a temperature between 15°C to 30°C (59°F to 86°F). The package insert should be consulted for dosage and administration instructions. These tablets are distributed by Zameer Pharmaceuticals LLC and manufactured by Piramal Pharma Limited in India for Piramal Healthcare UK Ltd. It is important to keep this medication out of the reach of children and dispense it in a light-resistant and child-resistant container.*
Structure - image 01
Label 500 mg - r500mg
This text provides information about Ranolazine, an extended-release tablet used for treating certain heart conditions. Each tablet contains 500 mg of ranolazine and should be swallowed whole without crushing, breaking, or chewing. The tablets should be stored at room temperature and kept out of reach of children in a light-resistant, child-resistant container. The manufacturing details and distribution information are also included in the text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
